InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: north40000 post# 311111

Friday, 09/08/2017 11:03:00 AM

Friday, September 08, 2017 11:03:00 AM

Post# of 345952
“...there also were drugs approved without control groups...”

“...the F.D.A. has not insisted on large trials with control groups...”

Peregrine has suffered through large ‘over achieving control arm anomalies’ in a number of its cancer trials, where the Bavituximab treatment arm performed strongly, as per design.

Starting with the 2012 phase ll NSCLC trial, where the control arm was sabotaged by a person at the contracted CMO. The 3mg/kg Bavi arm was not interfered with, and performed strongly, doubling standard survival.

These over achieving control arms made it impossible for the FDA to accept any of these Bavituximab trials.

This happened way too often to have been by chance.

Only the control arms were irregular, the active Bavituximab arms performed per design, and as expected by Peregrine.

What seems obvious is that whoever may have engineered these over achieving control arms did not want to damage the active Bavituximab arms. The ultimate perpetrator had an extreme interest in Bavituximab, anti-PS technology.

So much so, that the interfering party was willing to act illegally on multiple occasions. That amounts to an astronomical risk.

Recently, a hedge fund has taken a run at PPHM for control of the company.

What’s in the works for anti-PS technology??

The pressure on shareholders has been immense.

IMO

sunstar

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News